UTHR · Categories · Upgrades
UTHR - Analyst upgrades
United Therapeutics Corporation (UTHR) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for UTHR
- United Therapeutics upgraded by Wells Fargo with a new price targetWells Fargo upgraded United Therapeutics from Equal Weight to Overweight and set a new price target of $735.00
- United Therapeutics upgraded by BofA Securities with a new price targetBofA Securities upgraded United Therapeutics from Underperform to Neutral and set a new price target of $314.00
- United Therapeutics upgraded by Goldman with a new price targetGoldman upgraded United Therapeutics from Sell to Neutral and set a new price target of $215.00 from $213.00 previously
- United Therapeutics upgraded by Argus Research with a new price targetArgus Research upgraded United Therapeutics from Hold to Buy and set a new price target of $205.00
- United Therapeutics upgraded by HC Wainwright & Co. with a new price targetHC Wainwright & Co. upgraded United Therapeutics from Neutral to Buy and set a new price target of $195.00 from $125.00 previously